GainsWave vs P-Shot: Which ED and Performance Treatment Is Right for You?

GainsWave (low-intensity shockwave therapy) and the P-Shot (platelet-rich plasma injection) are two of the most discussed non-pharmaceutical ED treatments offered at men's health clinics today. Both are marketed as ways to improve erectile function, enhance sensitivity, and optimize sexual performance without drugs or surgery. But they work through completely different biological mechanisms — and their evidence bases are not equivalent. Understanding the distinction helps men make a genuinely informed choice.

How GainsWave (Acoustic Wave Therapy) Works

GainsWave is a branded protocol for low-intensity extracorporeal shockwave therapy (Li-ESWT) applied to the penis. The device delivers low-frequency acoustic waves — not electrical shocks — to penile tissue through an external applicator pressed against the skin.

The proposed mechanism is neovascularization and microplaque disruption. In men with vasculogenic erectile dysfunction (the most common type, caused by reduced penile blood flow), penile arterial tissue develops microplaques that restrict circulation. Acoustic waves applied to this tissue are thought to:

• Break up existing microplaques in penile blood vessels, improving arterial flow
• Trigger the release of angiogenic growth factors (particularly VEGF — vascular endothelial growth factor) that stimulate formation of new capillaries
• Activate dormant stem cells in penile tissue to support tissue regeneration

A standard GainsWave protocol consists of 6–12 sessions performed over 3–6 weeks, each lasting approximately 20–30 minutes. The treatment is performed in the office with no anesthesia — patients describe the sensation as a mild tapping vibration. There is no downtime.

GainsWave is specifically the brand name associated with a particular shockwave device and protocol. The underlying technology — Li-ESWT for ED — is also used under other brand names and protocols. The GainsWave name essentially refers to a standardized delivery protocol using certified devices.

How the P-Shot (PRP) Works

The Priapus Shot, or P-Shot, is a procedure in which platelet-rich plasma (PRP) derived from the patient's own blood is injected directly into the penile tissue. PRP is prepared by drawing a small amount of the patient's blood, spinning it in a centrifuge to concentrate the platelet-rich fraction, and activating that fraction to release growth factors.

Platelets contain numerous growth factors — including PDGF, TGF-β, IGF-1, VEGF, and FGF — that play roles in tissue repair, cell proliferation, and angiogenesis. When concentrated PRP is injected into the corpus cavernosum and the glans penis, the theory is that these growth factors:

• Promote formation of new penile blood vessels (angiogenesis)
• Support repair of damaged penile nerve tissue
• Stimulate smooth muscle cell growth within the corpora cavernosa
• Potentially improve penile sensitivity and response to stimulation

The P-Shot procedure takes approximately 60–90 minutes in a clinic setting, including blood draw, PRP preparation, and injection under local anesthesia. A penile nerve block is used to make the injections comfortable. The "Priapus Shot" name is trademarked and requires provider certification, though the underlying PRP injection technique is practiced by many sexual medicine physicians under various names.

What Each Treatment Targets

While both treatments are used for ED and sexual performance, they target different aspects of the problem and may be better suited to different patient profiles:

• GainsWave / Li-ESWT: Primarily targets vascular ED — the type caused by reduced blood flow due to arterial disease, diabetes, or cardiovascular risk factors. It works on the supply side of erectile function: getting more blood to the penile tissue. It is the better-studied of the two for straightforward vasculogenic ED.
• P-Shot / PRP: Targets tissue-level regeneration — promoting growth factor activity to potentially improve nerve function, tissue health, and vascular density at a cellular level. It may be particularly appropriate for men with Peyronie's disease, post-prostatectomy ED, or men seeking enhanced sensitivity alongside improved erectile function.

In practice, many clinics offer both treatments together as a combination protocol — the rationale being that shockwave therapy opens new vascular channels while PRP provides growth factors that support long-term tissue regeneration. Whether the combination delivers meaningfully better results than either treatment alone is an active research question.

Clinical Evidence Compared

The evidence base for Li-ESWT is more robust than for penile PRP. Multiple randomized controlled trials have examined low-intensity shockwave therapy for ED:

• A 2019 meta-analysis by Clavijo et al. in the Journal of Sexual Medicine analyzed 14 randomized controlled trials with 833 patients and found statistically significant improvements in International Index of Erectile Function (IIEF) scores compared to sham treatment, with effects most pronounced in men with mild-to-moderate vasculogenic ED.
• A 2021 Cochrane-style systematic review found that Li-ESWT improved erectile function compared to sham in the majority of trials, though it noted that effect sizes varied and that protocol standardization remains an issue across different device and delivery parameters.

For penile PRP (P-Shot), the evidence is less mature. A 2021 pilot randomized controlled trial published in Sexual Medicine found that PRP injection significantly improved IIEF scores and penile hemodynamics in men with vasculogenic ED compared to placebo at 3-month follow-up. However, the study included only 60 patients, and independent large-scale replication is limited.

The bottom line on evidence: Li-ESWT has more and better evidence supporting its use in vasculogenic ED. PRP has promising early data but fewer high-quality trials. Neither should be considered a proven equivalent to PDE5 inhibitor medications for most men with ED — they are better understood as adjunctive or alternative options, particularly for men who cannot or prefer not to use medication.

Results, Timeline, and Durability

GainsWave (Li-ESWT): Most men who respond to shockwave therapy begin noticing improvements in erectile quality after 3–6 treatment sessions. Full effects typically emerge 4–8 weeks after completing the protocol, as neovascularization is a biological process that takes time to mature. Duration of benefit reported in clinical studies ranges from 6 months to 2 years. Many providers recommend maintenance sessions every 12–18 months to sustain results.

P-Shot (PRP): Anecdotal and study-reported timelines for PRP suggest that noticeable improvements — if they occur — begin appearing 4–12 weeks after injection, as tissue regeneration and new capillary formation take time. Single-treatment duration data is limited; some providers recommend a series of 2–3 injections spaced 4–6 weeks apart for optimal outcomes. Duration of effect for PRP is generally reported as 12–18 months before re-treatment is needed.

Cost Comparison

Neither GainsWave nor the P-Shot is covered by health insurance, as both are considered experimental or cosmetic treatments for ED by most major insurers. Out-of-pocket costs as of 2026:

• GainsWave / Li-ESWT: $400–$600 per session; full protocol of 6–12 sessions totals $2,400–$7,200. Maintenance sessions add $400–$600 per visit annually.
• P-Shot: $1,200–$2,500 per injection session. A series of 2–3 injections totals $2,400–$7,500.

Combined GainsWave + P-Shot protocols (offered by many clinics as a package) typically range from $4,000–$10,000. Combination packages sometimes offer modest savings compared to buying each treatment at full per-session rates.

Side Effects and Safety Profiles

Both treatments have generally favorable safety profiles in published literature:

GainsWave / Li-ESWT:

• Minor discomfort during treatment (mild tapping sensation)
• Occasional mild bruising or transient penile soreness after sessions
• No reported serious adverse events in any published RCT
• Not appropriate for men with penile implants, penile cancer, or coagulopathy

P-Shot / PRP:

• Mild to moderate pain at injection sites (dorsal nerve block significantly reduces this)
• Temporary bruising and swelling, typically resolving within 1 week
• Because PRP uses the patient's own blood, allergic reaction or disease transmission risks are essentially zero
• Minor risk of infection at injection site (managed with standard sterile technique)
• No serious adverse events reported in published literature at standard doses

Which Treatment Should You Choose?

The choice between GainsWave, the P-Shot, or both depends on your specific situation:

• Choose GainsWave if: You have mild-to-moderate vasculogenic ED, you want the treatment with the strongest published evidence base, and you're looking for a series of quick sessions with no needles and no recovery time.
• Choose the P-Shot if: You have ED with a possible neurogenic or tissue-quality component (such as post-prostatectomy ED or Peyronie's disease), or you are specifically seeking improved penile sensitivity alongside erectile improvement.
• Consider both if: You want a comprehensive regenerative approach and have budget for a combination protocol. Many men who pursue one treatment eventually try the other; some clinics offer these together for a synergistic effect.
• Start with your doctor first: Before pursuing either treatment, rule out underlying causes of ED that have specific medical treatments (low testosterone, cardiovascular disease, medication side effects). PDE5 inhibitors (Cialis, Viagra) remain the most evidence-backed first-line ED treatment; GainsWave and the P-Shot are appropriate considerations after medical evaluation.

Whichever path you choose, select a clinic with documented experience in both modalities and a physician who conducts a proper pre-treatment evaluation rather than simply booking you for a package. The right treatment for the wrong patient produces poor results — and an honest provider will tell you if you're not a good candidate.